Vedanta Biosciences
A biotechnology company that develops medicines based on live bacterial consortia that can colonize the human intestine.
All edits by Sudhir Sikriwal
Edits on 18 Feb, 2021
Sudhir Sikriwal
Edits made to:
Article (+13/-13 characters)
Article
On December 24, 2018 Vedanta Biosciences completed their series C funding roundfunding round with $27 million in funding from Bill & Melinda Gates Foundation, Bristol-Myers Squibb, Rock Springs Capital, Invesco Asset Management, Seventure Partners, and PureTech Health. The company plans on using the funding to develop its product candidates derived from the microbiome.
Find more companies like Vedanta Biosciences
Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
